A Study of LY3050258 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a multiple dose study of LY3050258 in healthy men and postmenopausal women. This study will evaluate the safety and how well the body tolerates LY3050258. It will last approximately 14 weeks with a 2 week follow-up appointment after the last treatment with study drug.
Epistemonikos ID: 9bcfd7066a74cffcf6f5bc4647695065363268b6
First added on: May 11, 2024